by MASA | May 14, 2025 | Asthma, Clinical Research, Respiratory Diseases
Do you know someone who is diagnosed with Asthma for at least 1 year and between the ages of 12-80? You may be eligible for a study and receive compensation for time and travel >> SIGN UP HERE << or contact us and our research coordinator will be in touch...
by MASA | Apr 29, 2025 | Asthma, Clinical Research
Do you know someone who is diagnosed with Asthma for at least 1 year and between the ages of 12-17? You may be eligible for a study and receive compensation for time and travel >> SIGN UP HERE << or contact us and our research coordinator will be in touch...
by MASA | Mar 21, 2025 | springfield community
🏀 It’s March Madness time! 🏀 This year, Midwest Allergy Sinus Asthma and Respiratory is excited to be part of “Media Madness,” a fun Springfield community initiative organized by Woodward Community Media. Thirty-two local businesses—including us—were randomly matched...
by MASA | Mar 10, 2025 | Immunodeficiency Hypogammaglobulinemia, News, Rare Diseases
Deadline: March 21, 2025 Download CIIC Patient Scholarship Application 2025 : You can submit your application to your provider. CIIC Annual Patient Scholarship: Empowering PIDD and Rare Disease Patients The CIIC (Coalition of Immunology and Allergy Clinics) is proud...
by MASA | Dec 19, 2024 | Drug Updates
The U.S. Food and Drug Administration (FDA) has approved VTAMA® (tapinarof) cream, 1%, for the treatment of mild, moderate, or severe atopic dermatitis (AD) in adults and children aged 2 years and older. This approval expands the use of VTAMA, previously approved for...
